Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04454190 · ClinicalTrials.gov registry record
Development and Validation of a Model to Predict Fast Progression in Glaucoma
A clinical trial, sponsored by Duke University.
- Terminated
- Registry status
- 1,152
- Enrollment target
NCT04454190 is a clinical trial that was terminated before completion, run by Duke University. The registered enrollment target is 1,152 participants.
The verdict
NCT04454190 was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- 1,152 participants
- Enrollment target
Study Summary
1. The purpose of this study is to obtain genetic data on a well-defined population of patients with glaucoma that had accurate measurements of rates of structural and functional change over time. 2. The investigators aim to recruit 5,000 patients for Phase I and 100 patients for Phase II over a period of 2 years for obtaining blood samples which will be processed for extraction of DNA and genotyping. Phase II also includes eye examination. Patients will be selected from the Duke Glaucoma Registry (DGR) database and will be contacted by phone, mail or email using a standardized script and procedure. 3. Data analysis, based on patient-blind (no personal health information) data will take place at Duke and Genentech. No protected health information (PHI) will leave Duke. Standard statistical methods will be used to analyze the collected data and to develop predictive statistical models for fast progression in glaucoma. Risks from participating in the study are low and include loss of confidentiality and inherent issues related to drawing blood.
Interventions
- DIAGNOSTIC_TEST Collection of genetic material
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,152 participants |
| Start Date | 2021-07-20 |
| Est. Completion | 2023-04-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04454190
The ClinicalTrials.gov registry entry for NCT04454190 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1,152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Collection of genetic material is the first listed.
NCT04454190 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04454190 about?
NCT04454190 is a clinical study titled "Development and Validation of a Model to Predict Fast Progression in Glaucoma". 1. The purpose of this study is to obtain genetic data on a well-defined population of patients with glaucoma that had accurate measurements of rates of structural and functional change over time. 2. The investigators aim to recruit 5,000 patients for Phase I and 100 patients for Phase II over a per...
What is the current status of trial NCT04454190?
This trial is currently terminated. The enrollment target is 1,152 participants. The study started on 2021-07-20. Estimated completion is 2023-04-24.
What interventions are being tested in trial NCT04454190?
The interventions under investigation include: Collection of genetic material (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04454190?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.